Hypoxia coordinates the spatial landscape of myeloid cells within glioblastoma to affect survival.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
17 May 2024
Historique:
medline: 17 5 2024
pubmed: 17 5 2024
entrez: 17 5 2024
Statut: ppublish

Résumé

Myeloid cells are highly prevalent in glioblastoma (GBM), existing in a spectrum of phenotypic and activation states. We now have limited knowledge of the tumor microenvironment (TME) determinants that influence the localization and the functions of the diverse myeloid cell populations in GBM. Here, we have utilized orthogonal imaging mass cytometry with single-cell and spatial transcriptomic approaches to identify and map the various myeloid populations in the human GBM tumor microenvironment (TME). Our results show that different myeloid populations have distinct and reproducible compartmentalization patterns in the GBM TME that is driven by tissue hypoxia, regional chemokine signaling, and varied homotypic and heterotypic cellular interactions. We subsequently identified specific tumor subregions in GBM, based on composition of identified myeloid cell populations, that were linked to patient survival. Our results provide insight into the spatial organization of myeloid cell subpopulations in GBM, and how this is predictive of clinical outcome.

Identifiants

pubmed: 38758780
doi: 10.1126/sciadv.adj3301
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadj3301

Auteurs

Michael J Haley (MJ)

Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester, UK.
Lydia Becker Institute of Inflammation and Immunology, University of Manchester, Manchester, UK.

Leoma Bere (L)

Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester, UK.
Lydia Becker Institute of Inflammation and Immunology, University of Manchester, Manchester, UK.

James Minshull (J)

Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester, UK.
Division of Neuroscience, University of Manchester, Manchester, UK.

Sokratia Georgaka (S)

Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, UK.

Natalia Garcia-Martin (N)

Department of Statistics, University of Oxford, Oxford, UK.

Gareth Howell (G)

Flow Cytometry Core Research Facility, University of Manchester, Manchester, UK.

David J Coope (DJ)

Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester, UK.
Division of Neuroscience, University of Manchester, Manchester, UK.
Manchester Centre for Clinical Neurosciences, Manchester, UK.

Federico Roncaroli (F)

Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester, UK.
Division of Neuroscience, University of Manchester, Manchester, UK.
Manchester Centre for Clinical Neurosciences, Manchester, UK.

Andrew King (A)

Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester, UK.
Manchester Centre for Clinical Neurosciences, Manchester, UK.
Division of Cardiovascular Sciences, University of Manchester, Manchester, UK.

David C Wedge (DC)

Manchester Cancer Research Centre, University of Manchester, Manchester, UK.

Stuart M Allan (SM)

Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester, UK.
Division of Neuroscience, University of Manchester, Manchester, UK.

Omar N Pathmanaban (ON)

Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester, UK.
Division of Neuroscience, University of Manchester, Manchester, UK.
Manchester Centre for Clinical Neurosciences, Manchester, UK.

David Brough (D)

Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester, UK.
Lydia Becker Institute of Inflammation and Immunology, University of Manchester, Manchester, UK.
Division of Neuroscience, University of Manchester, Manchester, UK.

Kevin N Couper (KN)

Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester, UK.
Lydia Becker Institute of Inflammation and Immunology, University of Manchester, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH